Ravasio, R., M. Tiseo, L. Pradelli, M. Bellone, A. Gervasi, and M. Coffani. “Cost-Effectiveness Analysis of Alectinib Versus Crizotinib in First-Line Treatment of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer”. Global and Regional Health Technology Assessment 6, no. 1 (June 13, 2019). Accessed November 24, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/462.